Crossmark

Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study

Published Online: 2020-03-30

Published Print: 2020-12

Authors

Chang, Ying-Jun

Wang, Yu

Xu, Lan-Ping

Zhang, Xiao-Hui

Chen, Huan

Chen, Yu-Hong

Wang, Feng-Rong

Wei-Han,

Sun, Yu-Qian

Yan, Chen-Hua

Tang, Fei-Fei

Mo, Xiao-Dong

Liu, Yan-Rong

Liu, Kai-Yan

Huang, Xiao-Jun
Funding

Funding for this research was provided by:

National Key Research and Development Program of China (2017YFA0104500)

National Key Research and Development Program of China (2019YFC0840606)

Beijing Municipal Science and Technology Commission (Z181110009618032)

National Natural Science Foundation of China (81621001, 81530046, 81770189, 81470342)

Peking University Clinical Scientist Program (BMU2019LCKXJ003)
License Information

Text and Data Mining valid from 2020-03-30

Version of Record valid from 2020-03-30
More Information

Article History

Received: 9 January 2020

Accepted: 12 March 2020

First Online: 30 March 2020

Ethics approval and consent to participate

: The study protocol was approved by the Ethics Committee of Peking University People’s Hospital. The study is registered atNCT02185261. Informed consent was obtained from each patient.

: Not applicable

: The authors declared that they have no competing interests.

Document is current